种族与系统性硬化症诊断时未来发生硬皮病肾危象风险的关联
基于美国军事卫生系统2005至2016年电子病历的图表回顾,纳入31例硬皮病肾危象(SRC)病例和322例无SRC的SSc对照。调整年龄、eGFR、高血压和蛋白尿后,黑人患者未来发生SRC的风险显著高于非黑人患者(OR 6.4,95%CI 1.3-31.2,P=0.02)。黑人SRC患者抗Ro抗体阳性比例高于无SRC黑人患者(45% vs 14%,P=0.01)。
要点
- 黑人SSc患者未来发生SRC的风险显著高于非黑人患者(OR 6.4,95%CI 1.3-31.2)。
- 黑人SRC患者抗Ro抗体阳性比例高于无SRC黑人患者(45% vs 14%,P=0.01)。
- 非黑人队列中,较大年龄、血小板减少和抗RNA聚合酶III抗体与未来SRC显著相关。
核心结论
- 黑人种族与未来发生硬皮病肾危象(SRC)的风险升高独立相关。
- 需要进一步研究以阐明这一重要关联的机制。
研究设计与样本
- 利用美国军事卫生系统2005至2016年电子病历,对每例SSc患者进行综合图表回顾。
- 最终研究队列包括31例SRC病例和322例无SRC的SSc对照。
- 采用逻辑回归,以SRC为结局变量、种族(黑人 vs 非黑人)为主要预测变量,调整SSc诊断时年龄、估算肾小球滤过率、高血压和蛋白尿。
主要发现
- 353例患者中294例有种族记录(黑人79例,非黑人215例)。
- 黑人患者79例中13例(16.5%)发生SRC,非黑人患者215例中16例(7.4%)发生SRC(P=0.02)。
- 调整分析中,黑人患者发生SRC的风险显著高于非黑人患者(OR 6.4,95%CI 1.3-31.2,P=0.02)。
- 黑人SRC患者抗Ro抗体阳性比例为45%,高于无SRC黑人患者的14%(P=0.01)。
- 非黑人队列中,较大年龄、血小板减少和抗RNA聚合酶III抗体与未来SRC显著相关。
关键数值与推荐
- 黑人患者79例中13例(16.5%)发生SRC,非黑人患者215例中16例(7.4%)发生SRC(P=0.02)。
- 调整后黑人患者发生SRC的OR为6.4(95%CI 1.3-31.2,P=0.02)。
- 黑人SRC患者抗Ro抗体阳性45%,无SRC黑人患者为14%(P=0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出需要进一步研究以阐明该关联的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Scleroderma renal crisis (SRC) is a rare and severe manifestation of systemic sclerosis (SSc). Although it is well documented that Black patients with SSc have worse morbidity and mortality than non-Black patients, racial predilection for SRC is underreported. We examine the association of race and future development of SRC in an SSc cohort. METHODS: Using the electronic health record of the US Military Health System, we conducted a comprehensive chart review of each patient with SSc from 2005 to 2016. The final study cohort was comprised of 31 SRC cases and 322 SSc without SRC controls. We conducted logistic regression of SRC as the outcome variable and race (Black versus non-Black) as the primary predictor variable, adjusted for age, estimated glomerular filtration rate, hypertension, and proteinuria at SSc diagnosis. RESULTS: Of 353 patients, 294 had identifiable race (79 Black, 215 non-Black). Thirteen of 79 Black patients (16.5%) versus 16 of 215 (7.4%) non-Black patients developed SRC (P = 0.02). On adjusted analysis, Black patients had a significantly higher risk of developing SRC than non-Black patients (odds ratio 6.4 [95% confidence interval 1.3-31.2], P = 0.02). Anti-Ro antibody was present in a higher proportion of Black SRC patients versus Black patients without SRC (45% versus 14%, P = 0.01). Conversely, older age, thrombocytopenia, and anti-RNA polymerase III antibody at SSc diagnosis were significantly associated with future SRC in the non-Black cohort. CONCLUSION: Black race was independently associated with a higher risk of future SRC. Further studies are needed to elucidate the mechanisms that underlie this important association.
引用
- Forman CJ, Olson SW, Gordon SM, et al. Association of Race and Risk of Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis. Arthritis Care Res (Hoboken). 2022. PMID: 34738330. doi:10.1002/acr.24807
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。